The LIF (leukemia inhibitory factor)/LIFR (leukemia inhibitory factor receptor) cytokine signaling pathway has been linked to the progression of a variety of cancers; however, its importance in IBC has yet to be determined and was investigated in this study. This evidence concerns the gene LIFR and inflammatory breast carcinoma.